Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Henry Schein, Inc.
  6. Summary
    HSIC   US8064071025

HENRY SCHEIN, INC.

(HSIC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/03/2021 05/04/2021 05/05/2021 05/06/2021 05/07/2021 Date
74.01(c) 79.87(c) 78.91(c) 79.92(c) 80.61(c) Last
2 181 821 2 272 700 1 776 185 1 214 206 1 037 015 Volume
+2.08% +7.92% -1.20% +1.28% +0.86% Change
More quotes
Financials (USD)
Sales 2021 11 672 M - -
Net income 2021 559 M - -
Net Debt 2021 82,9 M - -
P/E ratio 2021 20,4x
Yield 2021 -
Sales 2022 11 852 M - -
Net income 2022 614 M - -
Net cash position 2022 200 M - -
P/E ratio 2022 18,6x
Yield 2022 -
Capitalization 11 244 M 11 244 M -
EV / Sales 2021 0,97x
EV / Sales 2022 0,93x
Nbr of Employees 20 000
Free-Float 99,0%
More Financials
Company
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
05/11 | 10:15amPresentation
More about the company
Notations Surperformance© of Henry Schein, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about HENRY SCHEIN, INC.
05/07INSIDER TRENDS : Henry Schein Insider Sale Scales Back 90-Days of Buys
MT
05/06INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of Henry S..
MT
05/06HENRY SCHEIN  : UBS Adjusts Henry Schein's Price Target to $69 From $59, Citing ..
MT
05/05HENRY SCHEIN  : Delivers Q1 Beat in "All Metrics;" Barrington Says
MT
05/05HENRY SCHEIN  : Barrington Adjusts Price Target on Henry Schein to $91 From $80,..
MT
05/04HENRY SCHEIN  : Management's discussion and analysis of financial condition and ..
AQ
05/04HENRY SCHEIN  : Vertical Market Data
PU
05/04HENRY SCHEIN  : Reconciliation of GAAP and Non-GAAP Measures
PU
05/04HENRY SCHEIN, INC. (NASDAQ : HSIC), the world's largest provider of health care ..
PU
05/04HENRY SCHEIN  : Reports Increased Q1 Results, Raises 2021 EPS Forecast
MT
05/04HENRY SCHEIN : Q1 Earnings Snapshot
AQ
05/04HENRY SCHEIN  : Earnings Flash (HSIC) HENRY SCHEIN Posts Q1 Revenue $2.9B, vs. S..
MT
05/04HENRY SCHEIN  : Earnings Flash (HSIC) HENRY SCHEIN Posts Q1 EPS $1.24, vs. Stree..
MT
05/04HENRY SCHEIN  : Reports Record First-Quarter 2021 Financial Results from Continu..
BU
04/27HENRY SCHEIN  : to Present at the Bank of America Securities 2021 Virtual Health..
BU
More news
News in other languages on HENRY SCHEIN, INC.
03/25HENRY SCHEIN  : asocia con la Black Coalition Against COVID-19 para intensificar..
2019USA/OPIOÏDES : J&J va verser 20 million de dollars pour éviter un procès fédéral
2019HENRY SCHEIN  : e Vets First Choice annunciano la composizione del CdA di Covetr..
2019HENRY SCHEIN  : und Vets First Choice geben Vorstand für Covetrus bekannt
2018HENRY SCHEIN E VETS FIRST CHOICE ANN : Covetrus
More news
Analyst Recommendations on HENRY SCHEIN, INC.
More recommendations
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 80,29 $
Last Close Price 80,61 $
Spread / Highest target 22,8%
Spread / Average Target -0,40%
Spread / Lowest Target -18,1%
EPS Revisions
Managers and Directors
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Gerald A. Benjamin Director, Chief Administrative Officer & EVP
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.20.57%11 244
CANTEL MEDICAL CORP.11.25%3 663
OWENS & MINOR, INC.24.36%2 578
SHIP HEALTHCARE HOLDINGS, INC.0.66%2 511
AS ONE CORPORATION-24.08%2 307
TOKAI CORP.17.59%782